Cerny-Reiterer, S; Herndlhofer, S; Stefanzl, G; Blatt, K; Hormann, G; Mullauer, L; Beham-Schmid, C; Baumgartner, S; Sperr, WSR; Mannhalter, C; Linkesch, W; Valent, P.
The tyrosine kinase inhibitor (TKI) imatinib produces mast cell deficiency in Ph plus chronic myeloid leukemia
ONKOLOGIE. 2013; 36: 63-63.
[Oral Communication]
Web of Science